--- title: "908 Devices | 8-K: FY2026 Q2 Revenue Beats Estimate at USD 16.07 M" type: "News" locale: "en" url: "https://longbridge.com/en/news/295526355.md" datetime: "2026-08-11T11:07:13.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/295526355.md) - [en](https://longbridge.com/en/news/295526355.md) - [zh-HK](https://longbridge.com/zh-HK/news/295526355.md) generator: "portal-rs" --- # 908 Devices | 8-K: FY2026 Q2 Revenue Beats Estimate at USD 16.07 M Revenue: As of FY2026 Q2, the actual value is USD 16.07 M, beating the estimate of USD 15.37 M. EPS: As of FY2026 Q2, the actual value is USD -0.32, missing the estimate of USD -0.17. EBIT: As of FY2026 Q2, the actual value is USD -11.95 M. #### Segment Revenue Total revenue for 908 Devices Inc. in the second quarter of 2026 was $16.1 million, marking a 23% increase over the prior year period. Recurring revenue constituted $4.9 million, representing 31% of total revenues for the quarter. Product revenue for the three months ended June 30, 2026, was $12,974 thousand, an increase from $9,577 thousand in the corresponding prior year period. Service and contract revenue was $3,100 thousand for the three months ended June 30, 2026, compared to $3,458 thousand for the corresponding prior year period. For the six months ended June 30, 2026, total revenue reached $29,456 thousand, up from $24,813 thousand in the corresponding prior year period. #### Operational Metrics ##### Gross Profit and Margin Gross profit for the second quarter of 2026 was $8.3 million, an increase from $6.4 million in the corresponding prior year period. GAAP gross margin stood at 52% for the second quarter of 2026, compared to 49% in the corresponding prior year period. Adjusted gross profit was $9.2 million for the second quarter of 2026, up from $7.3 million in the corresponding prior year period. Adjusted gross margin was 57% for the second quarter of 2026, showing an 85-basis point improvement from 56% in the second quarter of 2025. ##### Operating Expenses Total operating expenses for the second quarter of 2026 were $21.2 million, a decrease of $0.3 million from $21.5 million in the corresponding prior year period. Research and development expenses were $3,598 thousand for the second quarter of 2026, down from $4,405 thousand in the second quarter of 2025. Selling, general and administrative expenses were $11,112 thousand for the second quarter of 2026, compared to $10,337 thousand in the second quarter of 2025. The change in fair value of contingent consideration was $6,442 thousand for the second quarter of 2026, compared to $6,792 thousand in the second quarter of 2025. ##### Net Loss Net loss from continuing operations was - $11.9 million for the second quarter of 2026, an improvement from a net loss of - $12.9 million in the corresponding prior year period. Net loss attributable to common stockholders was - $11.9 million for the second quarter of 2026, compared to - $13.3 million in the corresponding prior year period. ##### Adjusted EBITDA Adjusted EBITDA was a loss of - $1.9 million for the second quarter of 2026, significantly reduced from a loss of - $3.9 million in the corresponding prior year period, representing a reduction of more than 50% year-over-year. #### Cash Position As of June 30, 2026, 908 Devices Inc. held $101.5 million in cash, cash equivalents, and marketable securities, with no outstanding debt. In the second quarter of 2026, - $13.5 million of cash and cash equivalents were utilized for the acquisition of NIRLAB SA. Additionally, $3.5 million was received from the release of the escrow from the desktop divestiture. #### Unique Metrics The installed base of devices grew 23% year-over-year, reaching 4,101 devices, with 198 devices placed during the second quarter of 2026. 908 Devices Inc. shipped more than 35 VipIR chemical identification devices in the quarter, including 18 units to a major South Asia law enforcement agency, and has surpassed its 100th VipIR unit shipped since launch. Subsequent to the quarter-end, the company secured a $6 million ProtectIR order from a corrections agency in the Asia-Pacific region, which is expected to support their second-half revenue outlook. #### Outlook / Guidance 908 Devices Inc. updated its full-year 2026 revenue guidance range to $68.0 million to $70.0 million, raising the low end of the range from $67.0 million previously. This revised guidance indicates a projected growth of 21% to 25% compared to 2025 revenue. The company expressed confidence in its team’s ability to deliver, citing a robust pipeline of opportunities. ### Related Stocks - [MASS.US](https://longbridge.com/en/quote/MASS.US.md) ## Related News & Research - [908 Devices CEO Kevin J. Knopp disposes of USD 283,477.32 in common shares](https://longbridge.com/en/news/296148424.md) - [908 Devices Eyes Growth in Handheld Drug and Chemical Detection Market](https://longbridge.com/en/news/295993916.md) - [908 Devices CEO Kevin J. Knopp disposes of USD 1.46 million in common shares](https://longbridge.com/en/news/295710071.md) - [Who Was Right About Tesla Robotaxi Deployment in 2025?](https://longbridge.com/en/news/296667986.md) - [Tesla Stock Price Prediction: SpaceX Thruster-Equipped Roadster May Debut This Month, Could It Boost TSLA Stock?](https://longbridge.com/en/news/296053807.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**